15
Participants
Start Date
June 3, 2024
Primary Completion Date
March 1, 2026
Study Completion Date
March 1, 2026
Olanzapine 2.5Mg Oral Tablet
"Olanzapine capsules (2.5mg) will be administered during one research visit for each menstrual cycle phase. The dosing schedule is as follows:~1. Day 0- 5mg~2. Day 1- 10mg"
Placebo
Placebo capsules visually identical to those containing olanzapine will be administered according to the same dosing schedule during one research visit of each menstrual cycle phase.
Insulin Lispro 100 UNT/ML
At each visit, participants will be given an intranasal insulin challenge (160 IU) to assess brain insulin signalling via MRI based assay.
Saline
At each visit, participants will be given an intranasal saline placebo (1.6 mL) in order to establish baseline brain insulin signalling via MRI based assay.
RECRUITING
Centre for Addiction and Mental Health (CAMH), Toronto
Centre for Addiction and Mental Health
OTHER